Hemophilia Drug Development (HDD 2021) is a conference dedicated to the most pressing challenges in the broad spectrum of novel therapies in the treatment of hemophilia.
Topics
Mechanisms in next generation therapies to understand the biological impacts
Optimizing patient-centric approaches to ensure patient engagement
How to define endpoints in the era of new drugs
The factors that influence patients to adopt novel therapies
Past Events
Hemophilia Drug Development (HDD 2021) - Aug 2021, Boston, Massachusetts, United States (75995)
Hemophilia Drug Development (HDD) - 18 Aug 2020, Online Event (84616)
Hemophilia Drug Development (HDD 2019) - 20-22 Aug 2019, Wyndham Boston Beacon Hill, Massachusetts, United States (84615)
Important
Please, check "Hemophilia Drug Development (HDD)" official website for possible changes, before making any traveling arrangements
